U S PHYSICAL THERAPY INC /NV Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
U S PHYSICAL THERAPY INC /NV (USPH) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of $28.37 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2019-05-06
- U S PHYSICAL THERAPY INC /NV net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2018-09-30 was $9.42M.
- U S PHYSICAL THERAPY INC /NV net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2018-06-30 was $10.63M.
- U S PHYSICAL THERAPY INC /NV net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2018-03-31 was $8.32M.
- U S PHYSICAL THERAPY INC /NV net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2016 was $26.27M.
- U S PHYSICAL THERAPY INC /NV net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2014 was $30.03M, a 43.02% increase from fiscal 2013.
- U S PHYSICAL THERAPY INC /NV net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2013 was $21.00M, a 19.92% decline from fiscal 2012.
- U S PHYSICAL THERAPY INC /NV net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2012 was $26.22M.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2018-09-30 | $9.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $20.05M derived: sum of 2 quarters · filed 2018-11-07 | $28.37M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $10.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $18.94M 10-Q · filed 2018-08-07 | ||
| 2018-03-31 | $8.32M 10-Q · filed 2019-05-06 | |||
| 2017-09-30 | $18.86M 10-Q · filed 2017-11-07 | |||
| 2016-12-31 | $26.27M 10-K · filed 2019-03-18 | |||
| 2014-12-31 | $30.03M 10-K · filed 2015-03-12 | |||
| 2013-12-31 | $21.00M 10-K · filed 2015-03-12 | |||
| 2012-12-31 | $26.22M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |